Data / Form D filings / ENRICH BIOSYSTEMS INC.
ENRICH BIOSYSTEMS INC.: Form D filings
ENRICH BIOSYSTEMS INC., a biotechnology company in Branford, CT, filed 4 Form D notices with the SEC between 2022 and 2025. The latest, on November 26, 2025, reports $1.5 million sold of a $1.5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21 BUSINESS PARK DRIVE, SUITE 4, Branford, CT, 06405
- Phone
- (203) 433-4739
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1931770
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | New notice | $1,500,000 | $1,450,000 | $50,000 | 4 | Nov 13, 2025 | sec.gov |
| May 20, 2024 | New notice | $750,000 | $750,000 | 10 | May 3, 2024 | sec.gov | |
| May 20, 2024 | New notice | $3,116,767 | $2,241,765 | $875,002 | 17 | May 3, 2024 | sec.gov |
| Jun 3, 2022 | New notice | $4,000,000 | $3,775,000 | $225,000 | 26 | May 16, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Wagner | Director | |
| Qi Zhao | Executive Officer, Director | |
| Christopher McLeod | Director | |
| Dong Wang | Executive Officer, Director | |
| Jay Teich | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Nov 24, 2025 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ENRICH BIOSYSTEMS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.